Induction Chemotherapy and Toripalimab for Larynx Preservation in Resectable Locally Advanced Laryngeal/ Hypopharyngeal Carcinoma: Preliminary Results of INSIGHT Study

被引：0
|
作者：
Ou, X. [1 ]
He, X. [1 ,2 ]
Wang, Y.
Hui, C. [1 ]
机构：
[1] Fudan Univ, Dept Radiat Oncol, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Fudan Univ, Dept Head & Neck Surg, Shanghai Canc Ctr, Shanghai, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
294
引用
收藏
页码：S99 / S99
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant therapy with chemotherapy and immune checkpoint inhibitor for laryngeal function preservation in locally advanced hypopharyngeal cancer
    Wu, San-Gang
    Wang, Run-Jie
    Zhou, Yi
    Luo, Xian-Yang
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [22] Neoadjuvant Chemotherapy Improves Feasibility of Larynx Preservation and Prognosis in Resectable Locally Advanced Cervical Esophageal Cancer
    Kubo, Yuto
    Nozaki, Ryoko
    Igaue, Shota
    Utsunomiya, Daichi
    Kubo, Kentaro
    Yamamoto, Shun
    Kurita, Daisuke
    Kashihara, Tairo
    Ishiyama, Koshiro
    Honma, Yoshitaka
    Oguma, Junya
    Kato, Ken
    Daiko, Hiroyuki
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (08) : 5083 - 5091
  • [23] Docetaxel-Cisplatin-Fluorouracil Induction Chemotherapy for Larynx Preservation in Patients with Locally Advanced Hypopharyngeal Cancer: Predictive Factors of Oncologic and Functional Outcomes
    Mattei, Pierre
    Gal, Jocelyn
    Chamorey, Emmanuel
    Dassonville, Olivier
    Poissonnet, Gilles
    Aloi, Deborah
    Barret, Mederic
    Safta, Inga
    Saada, Esma
    Sudaka, Anne
    Culie, Dorian
    Bozec, Alexandre
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (03)
  • [24] PD-1 Inhibitors combined with paclitaxel (Albumin-bound) and cisplatin for larynx preservation in locally advanced laryngeal and hypopharyngeal squamous cell carcinoma: a retrospective study
    Fang, Qi
    Xu, Pengfei
    Cao, Fei
    Wu, Di
    Liu, Xuekui
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (12) : 4161 - 4168
  • [25] PD-1 Inhibitors combined with paclitaxel (Albumin-bound) and cisplatin for larynx preservation in locally advanced laryngeal and hypopharyngeal squamous cell carcinoma: a retrospective study
    Qi Fang
    Pengfei Xu
    Fei Cao
    Di Wu
    Xuekui Liu
    Cancer Immunology, Immunotherapy, 2023, 72 : 4161 - 4168
  • [26] Results of an organ preservation protocol with induction chemotherapy and radiotherapy in patients with locally advanced pyriform sinus carcinoma
    X. León
    Miquel Quer
    César Orús
    Josep Morán
    Klaus Recher
    European Archives of Oto-Rhino-Laryngology, 2002, 259 : 32 - 36
  • [27] Results of an organ preservation protocol with induction chemotherapy and radiotherapy in patients with locally advanced pyriform sinus carcinoma
    León, X
    Quer, M
    Orús, C
    Morán, J
    Recher, K
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2002, 259 (01) : 32 - 36
  • [28] Neo-adjuvant (primary) organ-preserving chemotherapy in the management of locally advanced laryngeal carcinoma: Larynx preservation and clinical response
    Mantovani, G
    Gebbia, V
    Proto, E
    Cossu, F
    Bianchi, A
    Curreli, L
    Ghiani, M
    Massa, E
    Astara, G
    Lampis, B
    Dessi, D
    Santona, MC
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1996, 9 (05) : 1035 - 1043
  • [29] Neo-adjuvant (primary) organ-preserving chemotherapy in the management of locally advanced laryngeal carcinoma: Larynx preservation and clinical response
    Mantovani, G
    Curreli, L
    Bianchi, A
    Ghiani, M
    Astara, G
    Lampis, B
    Proto, E
    Cossu, F
    Gebbia, V
    10TH MEDITERRANEAN CONGRESS OF CHEMOTHERAPY, 1996, : 563 - 567
  • [30] Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II
    Dietz, A.
    Wichmann, G.
    Kuhnt, T.
    Pfreundner, L.
    Hagen, R.
    Scheich, M.
    Koelbl, O.
    Hautmann, M. G.
    Strutz, J.
    Schreiber, F.
    Bockmuehl, U.
    Schilling, V.
    Feyer, P.
    de Wit, M.
    Maschmeyer, G.
    Jungehuelsing, M.
    Schroeder, U.
    Wollenberg, B.
    Sittel, C.
    Muenter, M.
    Lenarz, T.
    Klussmann, J. P.
    Guntinas-Lichius, O.
    Rudack, C.
    Eich, H. T.
    Foerg, T.
    Preyer, S.
    Westhofen, M.
    Welkoborsky, H. J.
    Esser, D.
    Thurnher, D.
    Remmert, S.
    Sudhoff, H.
    Goerner, M.
    Buenzel, J.
    Budach, V.
    Held, S.
    Knoedler, M.
    Lordick, F.
    Wiegand, S.
    Vogel, K.
    Boehm, A.
    Flentje, M.
    Keilholz, U.
    ANNALS OF ONCOLOGY, 2018, 29 (10) : 2105 - 2114
12345